Physician's Attitude toward Treating Breakthrough Cancer Pain in Korea.
10.14475/kjhpc.2017.20.1.18
- Author:
Min Seok SEO
1
;
Jae Yong SHIM
;
Youn Seon CHOI
;
Do Yeun KIM
;
In Gyu HWANG
;
Sun Kyung BAEK
;
Jin Young SHIN
;
Juneyoung LEE
;
Chang Geol LEE
Author Information
1. Department of Family Medicine, Incheon St. Mary Hospital, The Catholic University of Korea College of Medicine, Incheon, Korea.
- Publication Type:Original Article
- Keywords:
Breakthrough pain;
Palliative care;
Opioid analgesics
- MeSH:
Analgesics, Opioid;
Breakthrough Pain;
Fentanyl;
Hospices;
Humans;
Korea*;
Morphine;
Oxycodone;
Palliative Care;
Surveys and Questionnaires
- From:Korean Journal of Hospice and Palliative Care
2017;20(1):18-25
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Adequate control of breakthrough pain is essential for patients with cancer. Managing breakthrough pain mainly depends on understanding the concept of breakthrough pain and the proper usage of rescue medication by physicians. This study aims to assess the attitudes and practice patterns of palliative physicians in managing breakthrough pain for patients in Korea. METHODS: This study was based on data from the 2014 breakthrough cancer pain survey conducted by the Korean Society for Hospice and Palliative Care. One hundred physicians participated in the online survey. Among total 33 self-reported questionnaires, twelve items were selected in this analysis. RESULTS: Rapid onset of action is the main influencing factor in selecting rescue opioids. Oral oxycodone (65%) and parenteral morphine (27%) are commonly used. A few physicians (3%) prefer to use transmucosal fentanyl. The percentage of physicians prescribing oral oxycodone due to its rapid onset of action is just 21.5%, whereas the percentage of physicians using parenteral morphine is 81.5%. Two thirds of respondents (66%) answered that breakthrough pain is not well controlled with rescue medications. CONCLUSION: There is a gap between the needs of physicians in terms of the perceived difficulties of managing breakthrough cancer pain and their practice patterns selecting rescue medications.
